Exhibit A2 shows the summary results for 2010 and 2013 after measurement of HACs was implemented and measured values replaced the baseline estimates shown in Exhibit A4 for 2010. Exhibit A3 shows just the percent change in HACs from the 2010 baseline to the interim 2013 rate. The cost savings and death reductions estimated for 2013 in Exhibit A2 are based on the measured 2010 and 2013 HACs and the estimated rates shown in Exhibit 1 and Exhibit A4 as to the additional cost per HAC and the additional inpatient mortality per HAC. As noted in the main body of this document, the overall measurement strategy for the PfP was published in the Journal of Patient Safety in September 2014 (http://journals.lww.com/journalpatientsafety/ Abstract/2014/09000/An_Overview_of_Measurement_Activities_in_the.2.aspx), and specific details as to how the HAC data and rates shown were acquired and calculated was posted starting in May 2014 on the AHRQ Web site; methods and 2010-2012 data are available at http://www.ahrq.gov/professionals/quality-patient-safety/pfp/index.html#methods.
Exhibit A2. AHRQ National Scorecard HACs for 2013 vs. 2010, and Projected 2013 Cost Savings and Reductions in Deaths Associated With HACs
PfP Hospital-Acquired Condition | 2010 Measured Baseline for HACs (rounded) | 2013 Measured HACs (rounded) | Measured Reduction in HACs (2010 vs. 2013) | Percent Reduction in Measured HACs (From 2010 to 2013) | Projected Cost Savings in 2013: Based on Measured Reductions of HACs in 2013 vs. 2010, and Baseline Projections Made in 2011 on the Additional Cost per HAC | Projected Reductions in Deaths in 2013: Based on Measured Reductions of HACs in 2013 vs. 2010, and Baseline Projections Made in 2011 on the Additional Inpatient Mortality per HAC |
---|---|---|---|---|---|---|
Adverse Drug Events | 1,621,000 | 1,320,000 | 301,000 | 19% | $1,505,000,000 | 6,020 |
Catheter-Associated Urinary Tract Infections | 400,000 | 290,000 | 110,000 | 28% | $110,000,000 | 2,563 |
Central Line-Associated Bloodstream Infections | 18,000 | 9,200 | 8,800 | 49% | $149,600,000 | 1,628 |
Falls | 260,000 | 240,000 | 20,000 | 8% | $144,680,000 | 1,100 |
Obstetric Adverse Events (2012 data used in lieu of 2013) | 82,000 | 77,000 | 5,000 | 6% | $15,000,000 | 7 |
Pressure Ulcers | 1,320,000 | 1,060,000 | 260,000 | 20% | $4,420,000,000 | 18,824 |
Surgical Site Infections | 96,000 | 78,000 | 18,000 | 19% | $378,000,000 | 508 |
Ventilator-Associated Pneumonias | 38,000 | 37,000 | 1,000 | 3% | $21,000,000 | 144 |
(Post-op) Venous Thromboembolisms | 28,000 | 23,000 | 5,000 | 18% | $40,000,000 | 520 |
All Other HACs (2013 MPSMS data and 2012 PSI data) | 894,000 | 823,000 | 71,000 | 8% | $1,207,000,000 | 3,216 |
Totals | 4,757,000 | 3,957,200 | 799,800 | 17% | $7,990,280,000 | 34,530 |